Want to see AMWL full AI Analyst Report?
AMWL Stock Chart & Stats
$10.81
$0.25(2.31%)
At close: 4:00 PM EDT
$10.81
$0.25(2.31%)
Day’s Range― - ―
52-Week Range$3.71 - $14.19
Previous CloseN/A
Volume57.88K
Average Volume (3M)94.74K
Market Cap
$202.40M
Enterprise Value-$27.81
Total Cash (Recent Filing)$195.95M
Total Debt (Recent Filing)$2.98M
Price to Earnings (P/E)―
Beta2.27
Next Earnings
Nov 10, 2026EPS Estimate
-0.78Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.77
Shares Outstanding15,361,463
10 Day Avg. Volume80,702
30 Day Avg. Volume94,738
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.33
Price to Sales (P/S)0.32
P/FCF Ratio-1.19
Enterprise Value/Market Cap>-0.01
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$12.80Price Target Upside18.41% Upside
Rating ConsensusHold
Number of Analyst Covering7
EPS Forecast (FY)-2.6
Revenue Forecast (FY)$203.15M
Bulls Say, Bears Say
Bulls Say
Strong Balance Sheet With Minimal LeverageAmwell's substantial cash balance and negligible debt reduce financial risk and provide flexibility to fund operations, execute its transformation plan, and pursue growth opportunities while it works toward operating cash-flow breakeven.
Cost Reductions Support A Path Toward BreakevenMaterial expense reductions and near-breakeven adjusted EBITDA indicate improving operating leverage. If maintained, this discipline can reduce cash consumption and strengthen the business model as revenue stabilizes.
DHA Award Intent Strengthens Strategic PositioningA potential three- to five-year DHA relationship would deepen Amwell's role in military health infrastructure, enhance enterprise credibility, and create a platform for additional government and commercial opportunities.
Bears Say
Sustained Revenue ContractionBroad declines in total and subscription revenue point to customer churn, portfolio changes, and difficult comparisons. Continued contraction could weaken scale benefits, delay operating leverage, and make the path to sustainable growth less certain.
Negative Cash Flow And Continuing LossesAmwell remains dependent on its cash reserves because operations are not yet self-funding. Persistent cash burn and negative net margins can erode financial resources over time, even with low leverage and improving loss levels.
DHA Realization And 2027 Growth Remain UncertainThe DHA intent to award is not yet equivalent to realized revenue, and expansion timing may extend into 2027. Dependence on unclosed contracts makes the topline recovery and operating-leverage thesis vulnerable to delays or weaker execution.
American Well News
AMWL FAQ
What was American Well’s price range in the past 12 months?
American Well lowest stock price was $3.71 and its highest was $14.19 in the past 12 months.
What is American Well’s market cap?
American Well’s market cap is $202.40M.
When is American Well’s upcoming earnings report date?
American Well’s upcoming earnings report date is Nov 10, 2026 which is in 79 days.
How were American Well’s earnings last quarter?
American Well released its earnings results on Aug 04, 2026. The company reported -$0.59 earnings per share for the quarter, beating the consensus estimate of -$0.86 by $0.27.
Is American Well overvalued?
According to Wall Street analysts American Well’s price is currently Undervalued.
Does American Well pay dividends?
American Well does not currently pay dividends.
What is American Well’s EPS estimate?
American Well’s EPS estimate is -0.78.
How many shares outstanding does American Well have?
American Well has 15,361,463 shares outstanding.
What happened to American Well’s price movement after its last earnings report?
American Well reported an EPS of -$0.59 in its last earnings report, beating expectations of -$0.86. Following the earnings report the stock price went up 24.952%.
Which hedge fund is a major shareholder of American Well?
Currently, no hedge funds are holding shares in AMWL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
American Well Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$12.80 (18.41% Upside)
$12.80 (18.41% Upside)
Blogger Sentiment
Neutral
AMWL Sentiment 67%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 3.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $328.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
11.54%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-15.82%
Trailing 12-Months
Company Description
American Well
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
AMWL Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
Mixed-but-cautiously-optimistic. The company shows meaningful operational progress: large cash reserves with no debt, substantial cost reductions, improved adjusted EBITDA (near breakeven), a healthier subscription mix (now >50% of revenue and up sequentially), and an independently validated clinical program. Strategic wins and credibility (DHA intent to award, Nature-published SilverCloud results) support upside. However, material year-over-year revenue and visit declines (total revenue −26.6%, subscription −36.5%, platform visits −28.4%) and timing uncertainty around DHA contract realization and near-term Q3 cost impacts keep the situation balanced. Management tightened guidance and raised full-year adjusted EBITDA expectations, but topline recovery in 2027 remains contingent on converting pipeline opportunities into signed contracts.View all AMWL earnings summariesAMWL Revenue Breakdown
46.12% Visits
43.37% Platform subscription
10.50% Other
AMWL Stock 12 Month Forecast
Average Price Target
$12.80
▲(18.41% Upside)
Technical Analysis
Ownership Overview
9.57% Insiders
10.53% Mutual Funds
16.95% Other Institutional Investors
58.16% Public Companies and
Individual Investors